Blue Water Acquisition in an amended prospectus filing said it intends to raise $50 million, focusing on targets in the healthcare or healthcare related industries in the United States and Europe, especially in the life sciences and pharmaceutical services sectors. Read more.
Related Posts
Direct Selling Acquisition Files for $200M IPO
The new SPAC in the filing said it will target domestically-based businesses within the direct selling industry with enterprise values from $500 million to $2.0 billion.
LatAmGrowth SPAC Prices $130M IPO
LatAmGrowth intends to focus its search on high-growth companies in Latin America, including Brazil, as well as businesses in the United States that cater to the Hispanic community.
BlueRiver Pushes Today’s Extension Vote to Aug. 2
Just this week, the SPAC announced a merger deal with Spinal Stabilization Technologies and a non-redemption agreement covering 200,000 shares.
Monocle Shareholders Approve Aersale Combination
The combined company has an enterprise value of $300 million.